Immutep IMMP
NASDAQ IMMP
$0.39 0.00 (-1.28%)
At close: Aug 21, 2026 · 4:00 PM EDT

Immutep (IMMP) Liabilities and Shareholders Equity (2011 - 2025)

Immutep's (IMMP) quarterly Liabilities and Shareholders Equity came in at $96.6 million in Q4 2025, down 18.94% YoY from $119.2 million in Q4 2024, and down 3.87% on a QoQ basis from $100.5 million in Q2 2025.

Immutep (IMMP) Liabilities and Shareholders Equity (2011 - 2025) Analysis & Trends

Immutep (IMMP) has 15 years of Liabilities and Shareholders Equity data on file, last reported at $96.6 million in Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 18.94% year-over-year to $96.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $449.3 million (up 4.19% YoY) and the FY2025 annual result came in at $100.5 million, down 24.32% from the prior year.
  • Liabilities and Shareholders Equity eased to $96.6 million in Q4 2025, from $100.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $132.8 million in Q2 2024 to a low of $56.5 million in Q4 2022.
  • A 5-year average of $90.9 million and a median of $92.1 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity jumped 106.83% — and 2022, when it tumbled 35.47%.
  • Tracing IMMP's Liabilities and Shareholders Equity over 5 years: stood at $87.6 million in 2021, then sank by 35.47% to $56.5 million in 2022, then soared by 42.6% to $80.6 million in 2023, then soared by 47.96% to $119.2 million in 2024, then decreased by 18.94% to $96.6 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $96.6 million (Q4 2025), $100.5 million (Q2 2025), and $119.2 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 10.96 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 9.18 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.56 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.60 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.10 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 Immutep 56.46 Mn -8.63 Mn - 96.65 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 96.65 Mn
Jun 30, 2025 100.54 Mn
Dec 31, 2024 119.23 Mn
Jun 30, 2024 132.85 Mn
Dec 31, 2023 80.59 Mn
Jun 30, 2023 98.55 Mn
Dec 31, 2022 56.51 Mn
Jun 30, 2022 73.18 Mn
Dec 31, 2021 87.57 Mn
Jun 30, 2021 63.17 Mn
Dec 31, 2020 55.90 Mn
Jun 30, 2020 30.54 Mn
Dec 31, 2019 29.35 Mn
Jun 30, 2019 23.92 Mn
Dec 31, 2018 34.61 Mn
Jun 30, 2018 35.58 Mn
Jun 30, 2017 26.27 Mn
Mar 31, 2017 26.78 Mn
Dec 31, 2016 28.63 Mn
Jun 30, 2016 31.78 Mn